Michael R. Jaff
There is now plentiful evidence that medical therapy benefits patients with peripheral artery disease, which is reflected in guidelines but not followed nearly enough, a speaker stated at the International Symposium on Endovascular Therapy.
“We…
Researchers at the University of Maryland School of Medicine (UMSOM) developed a new nanoparticle drug formulation that targets a specific receptor on cancer cells and appears to be more effective than a standard nanoparticle therapy currently…
Much attention has been given to the recent November 26, 2019 JAMA article that concluded U.S. life expectancy has declined for the past three years as a result of increased mortality among middle-aged adults from what has been…
Anesthesiologist Dr. Jerald Garcia, billed as a “top pain management specialist,” was one of the people who spoke. He explained to lawmakers why opioids have become so prevalent in our society. Dr. Garcia said it’s very hard to…
Holistic therapies tend to emphasize proper nutrition and avoidance of substances such as chemicals that pollute the body
Holistic medicine is a term used to describe therapies…
Woodruff Health Sciences Center | Jan. 23, 2020
Carlos del Rio, MD, executive associate dean for Emory University School of Medicine at Grady Health System, has been elected as the next…
William Schlaff, MD
Women with uterine fibroids who used elagolix (Orilissa) with add-back therapy saw a reduction in heavy menstrual bleeding.
Abnormal bleeding is 1 of the most common indications of uterine fibroids…
Raymond Douglas
Adults with thyroid eye disease assigned the human monoclonal antibody teprotumumab were significantly more likely to experience a meaningful improvement in proptosis after 21 weeks of treatment compared with those…
